Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    • News

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

Ingenia delivers despite challenges, holiday business bounces back

  • In News
  • July 1, 2022
  • Samantha Freidin
Ingenia delivers despite challenges, holiday business bounces back

My bag is packed, I’ve organised someone to look after the dog and I’ve already checked in for my flights online…I am well and truly READY to get the hell out of dodge this weekend for my first vacation in god knows how long. 

In recent years, the pesky pandemic has hindered many Aussies from shutting the laptop and going scram on their lives, even if it’s just for a weekend. And, while the rising cost of living has relegated international travel to those who can afford lettuce, the holiday business is rebounding. 

Owner, operator and developer of rental and holiday accommodation, Ingenia Communities (ASX: INA) has seen this trend reflected in their balance sheet as more people choose to holiday closer to home. 

With over 100 communities and sites earmarked for development in their portfolio, Ingenia is a well established player in the domestic holiday and property development market. 

In April, the Company released guidance figures anticipating EBIT growth of 5% to 10% and an underlying EPS of 1-2 cents below FY22. Despite a rocky few years, the Company is still expecting to deliver FY22 financial results within this guidance range, albeit on the lower end. 

The Group’s residential segment rounded out the financial year with an impressive settlements pipeline where 449 contracts and deposits are now in place. This puts Ingenia on course towards their longer term target of 1,800-2,000 settlements for the three years to FY24. The average Ingenia home sale price for the year was $406,000. 

The Company can expect their next challenge in the housing market crash, with experts warning that the Australian housing boom is well and truly over, a result of a slowing property market and rising interest rates. On the flip side of this, Ingenia will be able to acquire properties and land at significant discounts. 

Ingenia’s holiday business may well be the sweetness to offset the bitterness the property market is bound to experience. 

The Group’s holiday portfolio has a value of $678 million and is primarily focussed on the domestic family and grey nomad market with a variety of cabins, glamping tents, caravan and campsites along Australia’s eastern seaboard.

The business has “rebounded strongly following forced closures in the first half.” With more Aussies itching to use banked annual leave and the upcoming summer season, Ingenia is set to see increased traffic to their sites. 

In spite of weather related events in QLD and NSW, Ingenia saw its holiday business increase revenue by 45% compared to last year, with bookings through to June 2022 remaining strong. 

The Group expects to deliver their full FY22 financial results in late August. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • asx ina
  • domestic tourism
  • holiday
  • ina
  • ingenia communities
  • tourism
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.